Hypothesis

Young hypothalamic neural stem cells (hNSCs) secrete exosomal miRNAs that travel via circulation to the intestine, where they sustain a youthful epigenome in intestinal stem cells (ISCs) and enteric neurons by modulating DNA methyltransferase and demethylase activity. Age‑related decline of this brain‑derived signal permits epigenetic drift in the gut, contributing to microbiota‑driven inflammation and impairing the fidelity of iPSC reprogramming from gut‑derived cells. Restoring young hNSC exosomes should reset gut epigenetic age, ameliorate inflammation‑associated memory loss, and increase reprogramming efficiency.

Mechanistic Model

1. Source – hNSCs package specific miRNAs (e.g., miR‑29 family, miR‑124) into exosomes that cross the blood‑brain barrier and enter the portal circulation.
2. Target – Intestinal stromal niche cells uptake these exosomes; the miRNAs repress DNMT3A and up‑regulate TET2, preserving a balanced 5‑mC/5‑hmC landscape in ISCs.
3. Outcome – Balanced methylation maintains open chromatin at loci governing barrier function, mucin secretion, and vagal afferent signaling, limiting NF‑κB activation and medium‑chain fatty acid–induced inflammation.
4. Feedback – A healthy gut sends vagal afferent signals that reinforce hNSC activity, creating a positive loop. When the loop breaks with age, gut‑derived inflammation further suppresses hNSC exosome production, accelerating both brain and gut aging.

Testable Predictions

• Prediction 1: Aged mice receiving intravenous injections of exosomes isolated from young hNSCs will show a significant reduction in intestinal epigenetic age (measured by a gut‑specific Horvath clock) after 4 weeks, whereas exosomes from aged hNSCs or vehicle will not.
• Prediction 2: The same treatment will increase ISC proliferation (Ki‑67+ cells), enhance mucin‑2 expression, and lower colonic IL‑6 and TNF‑α levels, correlating with improved performance on hippocampal‑dependent memory tasks.
• Prediction 3: Gut‑derived fibroblasts or ISCs reprogrammed to iPSCs from treated mice will exhibit higher pluripotency marker expression (OCT4, NANOG) and lower residual methylation at gut‑specific loci compared with iPSCs from untreated aged controls.
• Prediction 4: Conditional knockout of exosome release factor Rab27a in hNSCs will accelerate gut epigenetic aging, increase gut permeability, and worsen memory decline, mimicking the effects of natural aging.

Falsifiability

If exogenous young hNSC exosomes fail to alter gut epigenetic age, ISC function, or memory outcomes despite confirmed delivery to the intestine, the hypothesis is refuted. Likewise, if Rab27a loss in hNSCs does not exacerbate gut aging phenotypes, the proposed brain‑to‑gut exocrine pathway is not required.

This framework flips the prevailing gut→brain bias, positioning the hypothalamus as an epigenetic pacemaker for the gut and offering a bottom‑up lever for longevity interventions.